13F filer · CIK 1704132
Foresite Capital Management IV, LLC
WEST HOLLYWOOD, CA · filing since Q4 2017 · last filing Aug 14, 2026
Reported value
$290.2M
+$53.1M vs prior
Positions
6
New / sold out
1 / 3
Added / reduced
2 / 0
Turnover
10.7%
buys $28.3M · sells $29.1M
Top-10 weight
100.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Added | CYTOKINETICS INC | +211,400 | +42.0% | +$18.0M |
| New | Crinetics Pharmaceuticals, Inc. | +150,000 | – | +$5.6M |
| Added | Relay Therapeutics, Inc. | +250,000 | +25.0% | +$4.7M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | Lyell Immunopharma, Inc. | -800,399 | -100.0% | $-16.1M |
| Sold out | Alector, Inc. | -3,887,200 | -100.0% | $-8.4M |
| Sold out | Maze Therapeutics, Inc. | -156,901 | -100.0% | $-4.7M |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Pharvaris N.V.COM | 4,778,581 | $165.2M | 56.95% |
| 2 | CYTOKINETICS INCCOM | 714,695 | $60.9M | 20.98% |
| 3 | Eikon Therapeutics, Inc.COM | 1,943,682 | $25.4M | 8.74% |
| 4 | Relay Therapeutics, Inc.COM | 1,250,000 | $23.4M | 8.06% |
| 5 | Xenon Pharmaceuticals Inc.COM | 160,000 | $9.7M | 3.33% |
| 6 | Crinetics Pharmaceuticals, Inc.COM | 150,000 | $5.6M | 1.93% |